GlassVC
Ansbert Gadicke

Ansbert Gadicke

Managing Partner · MPM BioImpact

General Partner

Dr. Ansbert Gadicke is Managing Partner of MPM BioImpact, which he founded in 1992 as a biotech venture firm and expanded across private and public biotechnology investing. He has been a lead investor and board member in companies including BioMarin, Pharmasset and Cullinan Therapeutics, and previously was a consultant at Boston Consulting Group.

Board seats

No public record

LAST CHECKED NOV 2026

Credited hits

6

· PUBLIC SOURCES

Midas years

No public record

LAST CHECKED NOV 2026

Founder rating

No public record

LAST CHECKED NOV 2026

Maintained from public sources. Not claimed. If you're Ansbert Gadicke, you can claim this profile.

Claim this profileHow claiming works

Claiming verifies identity and affiliation. It does not permit editing reviews, scores, or cited facts.

Track record

Credited deals only — Ansbert Gadicke is named in a public source as investor, lead, or board member on these deals. This is not a complete investment history, and absence here is not evidence of absence.
  • BioMarin Pharmaceuticalsipo

    Named in his MPM bio among companies where he has been a lead investor and board member; listed as NASDAQ: BMRN

    Source: mpmbioimpact.com

  • Idenix Pharmaceuticalsacquired

    Named in his MPM bio among companies where he has been a lead investor and board member; acquired by Merck & Co.

    Source: mpmbioimpact.com

  • Mitobridgeacquired

    Named in his MPM bio among companies where he has been a lead investor and board member; acquired by Astellas

    Source: mpmbioimpact.com

  • Pharmassetacquired

    Named in his MPM bio among companies where he has been a lead investor and board member; acquired by Gilead Sciences

    Source: mpmbioimpact.com

  • Cullinan Therapeuticsipo

    Named in his MPM bio among companies where he has been a lead investor and board member; listed as NASDAQ: CGEM

    Source: mpmbioimpact.com

  • ReNAgade Therapeuticsacquired

    Named in his MPM bio among companies where he has been a lead investor and board member (as Orna & ReNAgade Therapeutics); acquired by Eli Lilly

    Source: mpmbioimpact.com

Board seats

Current board seats · —

Board seats

No current board seats on record.

Success signals

Forbes Midas List

No public record

Not listed.

Reputation

No reputation score — basis not established for this investor.

No reputation sources on file yet.

Suggest a source

Contact

Published sources only

Published contact details collected from public sources. Not a referral, and not an introduction.

Published contact

Published sources only

GlassVC lists only contact information the firm or its sources have published. We do not list personal emails, direct lines, or private addresses.

Claimed profiles can replace or remove contact details.

What founders say

Founder-submitted · Verified identity and relationship

No founder reviews yet

Be the first founder to share your experience with Ansbert Gadicke. Reviews come from founders whose identity and relationship have been verified.

Write the first review
Reviews of MPM BioImpact (0) →

Firm-level reviews are not attributed to Ansbert Gadicke.

Methodology

This profile carries no tier: tier belongs to the firm and is shown only via the linked firm name — never inherited onto a person.

Credited deals, board seats, Midas years and reputation links are carried per investor in the catalog, each item with the public source it was credited from, linked from the sections above. Fields with no sourced record render their honest null states, and every published field traces to the catalog record listed below. Review dimension scores appear only at three or more reviews.

Corrections with a source: Suggest a correction.

Source record 1

  1. [1]

    DATABASE · GlassVC catalog — Catalog record for Ansbert Gadicke — provenance: GlassVC catalog

    CATALOG SOURCE FIELD · LAST CHECKED NOV 2026

    ↩ cites: Title · Firm · Type · Bio · Location · Focus · Credited deals

EVERY FIGURE ON THIS PAGE IS TRACEABLE TO THE CATALOG RECORD ABOVE · LAST CHECKED NOV 2026